Manufacturing

Abzena and Argonaut Partner to Streamline Biopharma Manufacturing
Management & Regulatory Abzena and Argonaut Partner to Streamline Biopharma Manufacturing

The collaboration between Abzena and Argonaut Manufacturing Services marks a significant milestone in the biopharmaceutical industry. These two leading Contract Development and Manufacturing Organizations (CDMOs) have embarked on a strategic partnership aimed at offering comprehensive solutions for

How Has Merck's €180M Boost Transformed Its German Hub?
Management & Regulatory How Has Merck's €180M Boost Transformed Its German Hub?

In a move that reaffirms its position as a powerhouse in the life sciences sector, Merck has made a resounding statement with a substantial €180 million investment to expand its distribution center in Schnelldorf, Germany. This ambitious project has nearly doubled the existing facility's size by an

How Will Sefia Revolutionize CAR-T Cell Therapy Production?
Management & Regulatory How Will Sefia Revolutionize CAR-T Cell Therapy Production?

The recent unveiling of the Sefia manufacturing platform by Cytiva, in partnership with Gilead Sciences’ Kite Pharma, marks a transformative step in the field of CAR-T cell therapy. With demand for these life-saving treatments increasing, the traditional production methods, fraught with manual

How Are Pharma Companies Enhancing Sustainability?
Management & Regulatory How Are Pharma Companies Enhancing Sustainability?

The pharmaceutical industry confronts a pivotal moment as the imperative to integrate sustainability throughout supply chains gains momentum. Amid shifting paradigms, companies are increasingly aware that business success is no longer measured solely in financial terms. Today's corporate climate

Merck to Buy Mirus Bio in $600M Deal to Boost Gene Therapy
Biotech & Bioprocessing Merck to Buy Mirus Bio in $600M Deal to Boost Gene Therapy

In a significant expansion of its life sciences portfolio, global science and technology leader Merck has announced a definitive agreement to purchase Mirus Bio for a staggering $600 million. Mirus Bio, a pioneering life sciences company, specializes in developing transfection reagents, a

NIBRT Opens €21M Biopharma Facility Boosting Ireland's Sector
Management & Regulatory NIBRT Opens €21M Biopharma Facility Boosting Ireland's Sector

The landscape of biopharmaceutical manufacturing in Ireland has recently welcomed an impressive addition with the inauguration of the National Institute for Bioprocessing Research and Training's (NIBRT) new facility. This state-of-the-art establishment in Dublin, conceived with a robust €21 million

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later